Shockwave Medical, Inc. (NASDAQ:SWAV) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET

Company Participants

Debbie Kaster - Vice President, Investor Relations

Doug Godshall - President and Chief Executive Officer

Isaac Zacharias - President and Chief Commercial Officer

Dan Puckett - Chief Financial Officer

Robert Fletcher - Senior Vice President, Marketing & Market Access

Conference Call Participants

Patrick Wood - Morgan Stanley

Travis Steed - Bank of America

Adam Maeder - Piper Sandler

Larry Biegelsen - Wells Fargo

Mike Matson - Needham & Company

Imron Zafar - Deutsche Bank

Michael Polark - Wolfe Research

Mike Kratky - Leerink

Danielle Antalffy - UBS

Operator

Good afternoon and welcome to Shockwave’s Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Debbie Kaster, Vice President of Investor Relations at Shockwave, for a few introductory comments.

Debbie Kaster

Thank you all for participating in today’s call. Joining me today from Shockwave Medical are Doug Godshall, President and Chief Executive Officer; Isaac Zacharias, President and Chief Commercial Officer; and Dan Puckett, Chief Financial Officer. Earlier today, Shockwave released its financial results for the quarter ended September 30, 2023. A copy of the press release is available on Shockwave’s website.

Before we begin, I would like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call other than statements of historical facts are forward-looking statements. All forward-looking statements, including, without limitation, statements related to our sales and operating trends, business and hiring prospects, financial and revenue expectations, reimbursement proposals, future product development and approvals in the integration of Neovasc and its technologies into our business are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties, including the impact of macroeconomic conditions and global events, such as the COVID-19 pandemic that could cause actual results or events to materially differ from those interpreted or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements.

For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our annual report on Form 10-K on file with the SEC and available on EDGAR and in our other reports filed periodically with the SEC. Shockwave disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise. This conference call contains time-sensitive information and is accurate only as of the live broadcast today, November 6, 2023.